Skip to main content
. Author manuscript; available in PMC: 2009 Aug 17.
Published in final edited form as: Surg Gynecol Obstet. 1979 Dec;149(6):815–821.

TABLE IV. REVISED STEPS IN MANAGEMENT.

  • STEP 1. Antibody assessment, same as Table II

  • STEP 2. Duration of pretreatment, cross match negative donor

    1. Antibody-free or cold antibodies … ≥ 28 days

    2. Warm anti-T or anti-B antibodies … ≥ 35 days

  • STEP 2 (alternative). Duration of pretreatment, cross match positive donor, same as Table II